Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06588634 · ClinicalTrials.gov registry record · NA
The PERSEVERE Study
A NA study of Pulmonary Embolism and Pulmonary Thromboembolism, sponsored by Inari Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 20
- Study locations
NCT06588634: Recruiting NA study of Pulmonary Embolism and Pulmonary Thromboembolism, sponsored by Inari Medical.
NCT06588634 is a NA study of Pulmonary Embolism and Pulmonary Thromboembolism that is actively recruiting participants, run by Inari Medical. The registered enrollment target is 200 participants, below the 3,054-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (93% lower). The trial reports 20 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06588634, a NA study of Pulmonary Embolism and Pulmonary Thromboembolism, is actively recruiting participants, sponsored by Inari Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 20
- Study locations
Study Summary
Randomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care
Primary Outcome
1. All-cause mortality 2. Cardiac arrest 3. Bailout to an alternative therapeutic strategy 4. Major bleeding 5. ECMO life support
Conditions Studied
Interventions
- PROCEDURE Standard of Care
- DEVICE FlowTriever System
Study Locations (20)
Other
- Besançon University Hospital - Besançon
- Hopital Arnaud de Villeneuve, Montpellier - Montpellier
- CHU Nîmes Caremeau - Nîmes
- Hôpital Européen Georges-Pompidou, Paris - Paris
- Klinikum Chemnitz - Chemnitz
- Universitätsklinikum Carl Gustav Carus an der TU Dresden - Dresden
- Universitätsmedizin Mainz - Mainz
- Munich LMU - München
Florida
- Orlando Health Regional Medical Center - Orlando
- Sarasota Memorial Hospital - Sarasota
New York
- Northwell Health - Bay Shore
- SUNY, The University at Buffalo - Buffalo
Pennsylvania
- UPHS Penn Health System - Philadelphia
- Allegheny General Hospital - Pittsburgh
Texas
- HCA Medical City Heart & Spine - Dallas
- HCA Methodist Health San Antonio - San Antonio
Connecticut
- Yale University - New Haven
Georgia
- Emory University - Atlanta
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-12-16 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
What NCT06588634 shows while recruiting
NCT06588634 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 3,054-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Pulmonary Embolism appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT06588634 names 20 study sites across 9 states, led by Other, Florida, New York.
Frequently Asked Questions
What is clinical trial NCT06588634 about?
NCT06588634 is a clinical study titled "The PERSEVERE Study". Randomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care
What is the current status of trial NCT06588634?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-12-16. Estimated completion is 2027-08-31.
What conditions does trial NCT06588634 study?
This clinical trial studies the following conditions: Pulmonary Embolism, Pulmonary Thromboembolism.
What interventions are being tested in trial NCT06588634?
The interventions under investigation include: Standard of Care (PROCEDURE), FlowTriever System (DEVICE).
Who is sponsoring clinical trial NCT06588634?
This trial is sponsored by Inari Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06588634 being conducted?
This trial has 20 study locations across Connecticut, Florida, Georgia, Mississippi, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06588634's enrollment target sits among peer trials
200 25th of 48 higher than 23 of 48 other Pulmonary Embolism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Embolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PEERLESS II Study
RECRUITING · NA
-
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
RECRUITING · NA
-
CLEANer Aspiration for Pulmonary Embolism
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI